Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03818334
What this trial is testing

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
Bone Marrow Transplant ComplicationsGraft Versus Host DiseaseInfection Viral+2 more
Hospital Israelita Albert Einstein 50
Not applicableStudy completedNCT01758484
What this trial is testing

Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant

Who this might be right for
Hematopoietic/Lymphoid Cancer
Fred Hutchinson Cancer Center 20
Not applicableUnknownNCT03031106
What this trial is testing

Multidisciplinary Follow-up of Patients Treated for Malignant Hematological Disease

Who this might be right for
Malignant Hematologic Neoplasm
Aalborg University Hospital 300
Very early researchLooking for participantsNCT04283006
What this trial is testing

CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies

Who this might be right for
Relapsed and RefractoryLymphoid Hematological Malignancies
He Huang 100
Testing effectiveness (Phase 2)Ended earlyNCT01685606
What this trial is testing

Study of Infusion of Blood Cells (Lymphocytes) to Stimulate the Immune System to Fight Leukemia/Lymphoma

Who this might be right for
Mantle Cell LymphomaDiffuse Large Cell LymphomaBurkitts Lymphoma+2 more
Brown University 6
Early research (Phase 1)Study completedNCT00446342
What this trial is testing

Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies

Who this might be right for
B-lymphoid MalignanciesChronic Lymphocytic LeukemiaMantle Cell Lymphoma+1 more
Sunesis Pharmaceuticals 21
Testing effectiveness (Phase 2)WithdrawnNCT01326273
What this trial is testing

Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation

Who this might be right for
CMV ReactivationAllogeneic Stem Cell TransplantationAutologous CMV Specific CD8+ T Cells
Imperial College London
Early research (Phase 1)UnknownNCT03344705
What this trial is testing

Safety and Efficacy Evaluation of IM19 Cells

Who this might be right for
Hematological Malignancies
Beijing Immunochina Medical Science & Technology Co., Ltd. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544466
What this trial is testing

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 75
Not applicableUnknownNCT04352556
What this trial is testing

COVID19-hematological Malignancies: the Italian Hematology Alliance

Who this might be right for
SARS-CoV-2 InfectionHematological Malignancies
Ospedale di Circolo - Fondazione Macchi 250
Early research (Phase 1)UnknownNCT05528887
What this trial is testing

Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies

Who this might be right for
Relapsed/Refractory Hematological MalignanciesLymphomaMyeloma+1 more
The Affiliated People's Hospital of Ningbo University 10
Not applicableStudy completedNCT04695431
What this trial is testing

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

Who this might be right for
Advanced Systemic MastocytosisAggressive Systemic MastocytosisSystemic Mastocytosis With an Associated Hematological Neoplasm+1 more
Blueprint Medicines Corporation 317
Not applicableStudy completedNCT01916057
What this trial is testing

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis

Who this might be right for
Invasive Fungal DiseaseChronic Disseminated CandidiasisHematological Malignancies+2 more
Assistance Publique - Hôpitaux de Paris 100
Not applicableNot Yet RecruitingNCT06674330
What this trial is testing

Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness

Who this might be right for
Hematological MalignanciesCritical Illness
National Taiwan University Hospital 600
Early research (Phase 1)Ended earlyNCT04553692
What this trial is testing

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

Who this might be right for
Solid TumorColorectal CancerNon Hodgkin Lymphoma+5 more
IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT03801122
What this trial is testing

Evolution of Thromboelastography During Tranexamic Acid Treatment

Who this might be right for
Hematological Malignancies Treated With Intensive Chemotherapy
Centre Hospitalier Universitaire de Saint Etienne 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07137481
What this trial is testing

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 70
Large-scale testing (Phase 3)Study completedNCT00469729
What this trial is testing

Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaLymphoid Leukemia+4 more
Gamida Cell -Teva Joint Venture Ltd. 101
Not applicableNot Yet RecruitingNCT07345780
What this trial is testing

Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies

Who this might be right for
CD7-Positive Hematological Malignancies
Donghua Zhang 28
Testing effectiveness (Phase 2)Study completedNCT00619645
What this trial is testing

Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, Davis 8
Next Page